AR003475A1 - Nuevos peptidos opiaceos, composiciones farmaceuticas que los contienen, el uso de los mismos en la preparacion de formulaciones y un metodo para su preparacion. - Google Patents
Nuevos peptidos opiaceos, composiciones farmaceuticas que los contienen, el uso de los mismos en la preparacion de formulaciones y un metodo para su preparacion.Info
- Publication number
- AR003475A1 AR003475A1 ARP960103900A AR10390096A AR003475A1 AR 003475 A1 AR003475 A1 AR 003475A1 AR P960103900 A ARP960103900 A AR P960103900A AR 10390096 A AR10390096 A AR 10390096A AR 003475 A1 AR003475 A1 AR 003475A1
- Authority
- AR
- Argentina
- Prior art keywords
- peptides
- preparation
- new
- phe
- formulations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Esta invención se refiere a nuevos péptidos opiáceos (I), y sales, derivados y sus análogos en los que, R1 es Tyr ó 2,6-dimetiltirosina, o unanálogo o su derivado;R2 es D-Ala ó D-Arg;R3 es Phe(p-F); R4 es Phe ó Phe(p-F); X es H o C1-6-alquil o; y Y y Z son independientemente H, aralquilo;ó -C1-6alquilo;tratamiento del dolor así como también al método para su preparación y a las composiciones farmacéuticamente aceptables que comprenden a estospéptidos.La invención también serefiere al u so de estos compuestos en la preparación de las formulaciones efectivas para el tratamiento del dolor. Lospéptidos de esta invención tienen un grado alto de selectividad para el receptor opiáceo (mu).Asimismo péptidos dela presente inv ención sonparticularmente analgésicos que actúan substancialmente sobre los receptores periféricos opiáceos my. Debido a que estos péptidos actúan periféricamente,evitan substancialmente los efectos colaterales normalmenteasociados con la acci ón analgésica central.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9502877A SE9502877D0 (sv) | 1995-08-18 | 1995-08-18 | Novel opioid peptides |
| SE9503924A SE9503924D0 (sv) | 1995-08-18 | 1995-11-07 | Novel opioid peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR003475A1 true AR003475A1 (es) | 1998-08-05 |
Family
ID=26662362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP960103900A AR003475A1 (es) | 1995-08-18 | 1996-08-06 | Nuevos peptidos opiaceos, composiciones farmaceuticas que los contienen, el uso de los mismos en la preparacion de formulaciones y un metodo para su preparacion. |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6337319B1 (es) |
| EP (1) | EP0845003B1 (es) |
| JP (1) | JPH11512086A (es) |
| KR (1) | KR19990037677A (es) |
| CN (1) | CN1200127A (es) |
| AR (1) | AR003475A1 (es) |
| AT (1) | ATE210148T1 (es) |
| AU (1) | AU711862B2 (es) |
| BR (1) | BR9610248A (es) |
| CA (1) | CA2229797A1 (es) |
| CZ (1) | CZ287299B6 (es) |
| DE (1) | DE69617699T2 (es) |
| DK (1) | DK0845003T3 (es) |
| EE (1) | EE9800048A (es) |
| ES (1) | ES2171224T3 (es) |
| HU (1) | HUP9901209A3 (es) |
| IL (1) | IL123258A (es) |
| IS (1) | IS4664A (es) |
| NO (1) | NO980592L (es) |
| NZ (1) | NZ315809A (es) |
| PL (1) | PL325113A1 (es) |
| RU (1) | RU2165432C2 (es) |
| SE (1) | SE9503924D0 (es) |
| SK (1) | SK282469B6 (es) |
| TR (1) | TR199800258T1 (es) |
| TW (1) | TW424095B (es) |
| WO (1) | WO1997007130A1 (es) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030032774A1 (en) * | 1994-02-21 | 2003-02-13 | Astrazeneca Ab | Novel opioid peptides for the treatment of pain |
| US5885958A (en) | 1997-03-25 | 1999-03-23 | Administrators Of The Tulane Educational Fund | Mu-opiate receptor peptides |
| SE9701718D0 (sv) * | 1997-05-07 | 1997-05-07 | Astra Ab | Analgesic peptidomimetic compounds |
| SE9800865D0 (sv) * | 1998-03-16 | 1998-03-16 | Astra Ab | New Process |
| AU6730500A (en) * | 1999-08-25 | 2001-03-19 | Daiichi Fine Chemical Co., Ltd. | Medicinal composition for percutaneous/permucosal absorption |
| AU1623801A (en) | 1999-11-19 | 2001-05-30 | Palatin Technologies, Inc. | Opioid metallopeptide compositions and methods |
| AU2001277908A1 (en) | 2000-07-18 | 2002-01-30 | Cornell Research Foundation Inc. | Medicinal uses of mu-opioid receptor agonists |
| JP2002069059A (ja) * | 2000-08-28 | 2002-03-08 | Teikoku Seiyaku Co Ltd | ピラジノン環を含む新規なオピオイドペプチド誘導体 |
| US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
| US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
| DE10361596A1 (de) * | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
| DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
| DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
| JP2008514612A (ja) * | 2004-09-23 | 2008-05-08 | ミシャロウ、アレクサンダー | 対抗適応を誘発することにより神経伝達物質系を調節する方法 |
| US20080045610A1 (en) * | 2004-09-23 | 2008-02-21 | Alexander Michalow | Methods for regulating neurotransmitter systems by inducing counteradaptations |
| DE102005005449A1 (de) * | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| US7825231B2 (en) | 2005-06-01 | 2010-11-02 | Darren P. Wolfe | Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy |
| EP1782819A1 (en) | 2005-11-03 | 2007-05-09 | Cognis IP Management GmbH | Oligopeptides and their use |
| US7713937B2 (en) | 2006-11-10 | 2010-05-11 | Cara Therapeutics, Inc. | Synthetic peptide amides and dimeric forms thereof |
| US8236766B2 (en) | 2006-11-10 | 2012-08-07 | Cara Therapeutics, Inc. | Uses of synthetic peptide amides |
| US7842662B2 (en) | 2006-11-10 | 2010-11-30 | Cara Therapeutics, Inc. | Synthetic peptide amide dimers |
| US8906859B2 (en) | 2006-11-10 | 2014-12-09 | Cera Therapeutics, Inc. | Uses of kappa opioid synthetic peptide amides |
| CA2667155C (en) | 2006-11-10 | 2016-05-10 | Cara Therapeutics, Inc. | Synthetic peptide amides |
| JP5774853B2 (ja) | 2008-01-25 | 2015-09-09 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 医薬投薬形 |
| EP2273983B1 (en) * | 2008-05-09 | 2016-07-20 | Grünenthal GmbH | Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step |
| EP2997965B1 (en) | 2009-07-22 | 2019-01-02 | Grünenthal GmbH | Tamper-resistant dosage form for oxidation-sensitive opioids |
| CA2765971C (en) | 2009-07-22 | 2017-08-22 | Gruenenthal Gmbh | Hot-melt extruded controlled release dosage form |
| US9579285B2 (en) * | 2010-02-03 | 2017-02-28 | Gruenenthal Gmbh | Preparation of a powdery pharmaceutical composition by means of an extruder |
| US20160176930A1 (en) | 2010-07-09 | 2016-06-23 | The Administrators Of The Tulane Educational Fund | Mu opioid receptor agonist analogs of the endomorphins |
| PE20131102A1 (es) | 2010-09-02 | 2013-10-12 | Gruenenthal Chemie | Forma de dosificacion resistente a manipulacion que comprende una sal inorganica |
| AR082862A1 (es) | 2010-09-02 | 2013-01-16 | Gruenenthal Gmbh | Forma de dosificacion resistente a alteracion que comprende un polimero anionico |
| EA201400172A1 (ru) | 2011-07-29 | 2014-06-30 | Грюненталь Гмбх | Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства |
| AR087359A1 (es) | 2011-07-29 | 2014-03-19 | Gruenenthal Gmbh | Tableta a prueba de alteracion que proporciona liberacion inmediata del farmaco |
| EP2819656A1 (en) | 2012-02-28 | 2015-01-07 | Grünenthal GmbH | Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer |
| AU2013248351B2 (en) | 2012-04-18 | 2018-04-26 | Grunenthal Gmbh | Tamper resistant and dose-dumping resistant pharmaceutical dosage form |
| US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
| CN102964279B (zh) * | 2012-12-12 | 2014-05-07 | 中国药科大学 | 一类具有外周镇痛作用的κ阿片受体激动剂 |
| AR096438A1 (es) | 2013-05-29 | 2015-12-30 | Gruenenthal Gmbh | Forma de dosificación resistente al uso indebido con perfil de liberación bimodal, proceso |
| AU2014273227B2 (en) | 2013-05-29 | 2019-08-15 | Grunenthal Gmbh | Tamper-resistant dosage form containing one or more particles |
| KR20160031526A (ko) | 2013-07-12 | 2016-03-22 | 그뤼넨탈 게엠베하 | 에틸렌-비닐 아세테이트 중합체를 함유하는 템퍼 내성 투여형 |
| BR112016010482B1 (pt) | 2013-11-26 | 2022-11-16 | Grünenthal GmbH | Preparação de uma composição farmacêutica em pó por meio de criomoagem |
| AU2015261060A1 (en) | 2014-05-12 | 2016-11-03 | Grunenthal Gmbh | Tamper resistant immediate release capsule formulation comprising Tapentadol |
| MX2016015417A (es) | 2014-05-26 | 2017-02-22 | Gruenenthal Gmbh | Multiparticulas protegidas contra vertido de dosis etanolico. |
| WO2016170097A1 (en) | 2015-04-24 | 2016-10-27 | Grünenthal GmbH | Tamper-resistant dosage form with immediate release and resistance against solvent extraction |
| JP2018526414A (ja) | 2015-09-10 | 2018-09-13 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG64368A1 (en) * | 1988-06-30 | 1999-04-27 | Astra Ab | Dermorphin analogs their methods of preparation pharmaceutical compositions and methods of therapeutic treatment using the same |
| IS4261A (is) | 1994-02-21 | 1995-08-22 | Astra Aktiebolag | Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra |
-
1995
- 1995-11-07 SE SE9503924A patent/SE9503924D0/xx unknown
-
1996
- 1996-08-06 AR ARP960103900A patent/AR003475A1/es active IP Right Grant
- 1996-08-14 JP JP9509209A patent/JPH11512086A/ja active Pending
- 1996-08-14 CZ CZ1998401A patent/CZ287299B6/cs not_active IP Right Cessation
- 1996-08-14 EE EE9800048A patent/EE9800048A/xx unknown
- 1996-08-14 NZ NZ315809A patent/NZ315809A/xx unknown
- 1996-08-14 PL PL96325113A patent/PL325113A1/xx unknown
- 1996-08-14 AU AU67600/96A patent/AU711862B2/en not_active Ceased
- 1996-08-14 WO PCT/SE1996/001011 patent/WO1997007130A1/en not_active Application Discontinuation
- 1996-08-14 RU RU98104253/04A patent/RU2165432C2/ru active
- 1996-08-14 SK SK203-98A patent/SK282469B6/sk unknown
- 1996-08-14 CN CN96197625A patent/CN1200127A/zh active Pending
- 1996-08-14 CA CA002229797A patent/CA2229797A1/en not_active Abandoned
- 1996-08-14 IL IL12325896A patent/IL123258A/xx not_active IP Right Cessation
- 1996-08-14 DE DE69617699T patent/DE69617699T2/de not_active Expired - Fee Related
- 1996-08-14 DK DK96927978T patent/DK0845003T3/da active
- 1996-08-14 AT AT96927978T patent/ATE210148T1/de not_active IP Right Cessation
- 1996-08-14 ES ES96927978T patent/ES2171224T3/es not_active Expired - Lifetime
- 1996-08-14 HU HU9901209A patent/HUP9901209A3/hu unknown
- 1996-08-14 US US08/718,585 patent/US6337319B1/en not_active Expired - Fee Related
- 1996-08-14 TR TR1998/00258T patent/TR199800258T1/xx unknown
- 1996-08-14 KR KR1019980701156A patent/KR19990037677A/ko not_active Application Discontinuation
- 1996-08-14 BR BR9610248A patent/BR9610248A/pt unknown
- 1996-08-14 EP EP96927978A patent/EP0845003B1/en not_active Expired - Lifetime
- 1996-08-15 TW TW085109918A patent/TW424095B/zh not_active IP Right Cessation
-
1998
- 1998-02-04 IS IS4664A patent/IS4664A/is unknown
- 1998-02-11 NO NO980592A patent/NO980592L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ315809A (en) | 1999-05-28 |
| AU6760096A (en) | 1997-03-12 |
| TR199800258T1 (xx) | 1998-05-21 |
| EP0845003A1 (en) | 1998-06-03 |
| BR9610248A (pt) | 1999-07-06 |
| US6337319B1 (en) | 2002-01-08 |
| HUP9901209A2 (hu) | 1999-08-30 |
| CZ40198A3 (cs) | 1998-08-12 |
| DK0845003T3 (da) | 2002-07-15 |
| ATE210148T1 (de) | 2001-12-15 |
| TW424095B (en) | 2001-03-01 |
| DE69617699D1 (de) | 2002-01-17 |
| CA2229797A1 (en) | 1997-02-27 |
| RU2165432C2 (ru) | 2001-04-20 |
| SE9503924D0 (sv) | 1995-11-07 |
| SK282469B6 (sk) | 2002-02-05 |
| JPH11512086A (ja) | 1999-10-19 |
| IS4664A (is) | 1998-02-04 |
| WO1997007130A1 (en) | 1997-02-27 |
| AU711862B2 (en) | 1999-10-21 |
| EE9800048A (et) | 1998-08-17 |
| NO980592D0 (no) | 1998-02-11 |
| CN1200127A (zh) | 1998-11-25 |
| IL123258A0 (en) | 1998-09-24 |
| PL325113A1 (en) | 1998-07-06 |
| IL123258A (en) | 2003-03-12 |
| DE69617699T2 (de) | 2003-08-07 |
| CZ287299B6 (en) | 2000-10-11 |
| KR19990037677A (ko) | 1999-05-25 |
| ES2171224T3 (es) | 2002-09-01 |
| NO980592L (no) | 1998-02-11 |
| HUP9901209A3 (en) | 2000-12-28 |
| EP0845003B1 (en) | 2001-12-05 |
| SK20398A3 (en) | 1998-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR003475A1 (es) | Nuevos peptidos opiaceos, composiciones farmaceuticas que los contienen, el uso de los mismos en la preparacion de formulaciones y un metodo para su preparacion. | |
| ES2163444T3 (es) | Composiciones y metodos para la administracion oral de farmacos. | |
| ES2166166T3 (es) | Analogos de peptido lh-rh, sus usos y composiciones farmaceuticas que los contienen. | |
| ES2128791T3 (es) | Derivados espirocetales, composiciones que los contienen y su uso como agentes terapeuticos. | |
| GT199700095A (es) | Derivados 6,5-heterobiciclicos sustituidos. | |
| PH16791A (en) | Angiotensin-ii analogues with antagonizing effects,containing an ester group in position 8 | |
| ES2167592T3 (es) | Preparaciones medicamentosas que contienen un enantiomero de bromuro de ipratropio con duracion de la accion prolongada. | |
| ES2168487T3 (es) | Derivados de n-heteroaril-piridinasulfonamida y su uso como antagonistas de la endotelina. | |
| ES2159738T3 (es) | Derivados de benzamida y su uso como antagonistas de vasopresina. | |
| CO4290424A1 (es) | Pirazolopiridinas, pirrolopiridinas, composiciones farmaceu- ticas que las contienen y procedimientos para su administra- cion como antagonista del factor de liberacion de cortico- tropina | |
| MX9301929A (es) | Derivados de pirimidina y procedimientos para su preparacion. | |
| SE9604341D0 (sv) | Hepta-peptide oxytocin analogue | |
| AR003966A1 (es) | Un derivado de difenilmetilenpiperidina, composición farmacéutica que lo contiene, metodo de preparación de dicho derivado y uso de este ultimo para preparar un medicamento | |
| GT199700037A (es) | Composiciones farmaceuticas para el tratamiento de la rinitis | |
| AR002268A1 (es) | Antagonistas de vasopresina de benzacepina triciclicos, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso dedichos compuestos para preparar composiciones farmaceuticas. | |
| ES2179996T3 (es) | Cefalosporinas de vinil-pirrolidinona con sustituyentes basicos. | |
| MX9400255A (es) | Analogos de peptidos opioides, metodo para su preparacion y composiciones farmaceuticas que los incluyen. | |
| DE69824313D1 (de) | Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen | |
| AR005102A1 (es) | Compuestos derivados de octahidro-pirrolo [1,2-a]-pirazina 2,7-sustituidos, composiciones farmaceuticas y uso de dichos compuestos para la fabricacion deun medicamento. | |
| ES2093782T3 (es) | Piridazindionas y su uso en el tratamiento de trastornos neurologicos. | |
| ES2189956T3 (es) | Derivados de quinolina, procedimientos para su preparacion y su uso como medicamentos. | |
| EP0553113A4 (es) | ||
| ES2174220T3 (es) | Uso de derivados de 4-fenil-3,6-dihidro-2h-piridilo como agentes bloqueantes de subtipos de receptores nmda. | |
| ES2171445T3 (es) | Nuevos oligopeptidos con afinidad para receptores opioides. | |
| DE69412612D1 (de) | Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |